about
Gemcitabine plus epirubicin in patients with advanced urothelial carcinoma who are not eligible for platinum-based regimens.Chemotherapy and management of bladder tumours.Incident urothelial cancer in the Malmö Diet and Cancer Study: cohort characteristics and further validation of ezrin as a prognostic biomarker.Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer.Treatment Response Assessment for Bladder Cancer on CT Based on Computerized Volume Analysis, World Health Organization Criteria, and RECIST.Membranous expression of podocalyxin-like protein is an independent factor of poor prognosis in urothelial bladder cancer.Pharmacogenomics in bladder cancer.Bladder Cancer Segmentation in CT for Treatment Response Assessment: Application of Deep-Learning Convolution Neural Network-A Pilot Study.S100A9 and EGFR gene signatures predict disease progression in muscle invasive bladder cancer patients after chemotherapy.Predicting response of bladder cancers to gemcitabine and carboplatin neoadjuvant chemotherapy through genome-wide gene expression profilingAssociation of ERCC1 SNPs with outcome in platinum-treated patients with advanced urothelial cancer: a Hellenic Cooperative Oncology Group study.Could salvage surgery after chemotherapy have clinical impact on cancer survival of patients with metastatic urothelial carcinoma?Borealis-1: a randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancer.
P2860
Q33344322-4EEFA6C1-3789-4E15-ADCF-CCD17ADC117EQ33874502-D66F8755-5339-4485-9F46-B5FFDD34DF6EQ34333522-5393EB78-0D02-48FD-98A0-28E4FAF3789FQ34658794-4A5C2A3C-2341-4C98-A488-C2FB34A105E0Q36686291-94C9B360-712B-4A3E-9BA1-92A9E47CD3F4Q36924797-85C616EF-08F8-4339-AD51-B19EF98A6EB1Q37523551-8A7DE2D1-0E0B-45FA-80DA-500A273174C4Q37590311-F9C7720B-AECE-4475-841B-AEBDE67326B4Q39015239-2A6EE206-D7D7-46AB-ABF3-38BDF405993EQ42715876-76EFEEC4-6C13-4188-8C4C-61D20D3E67AAQ43951894-A116A567-78A1-4CA6-9425-CCCB81CCE542Q45342949-C4FBE1C8-43C2-43C0-9E63-D8EF19873ECFQ47568177-F0F0114B-193D-46B2-BE75-4745FF15FCBA
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
The treatment of advanced bladder cancer.
@en
type
label
The treatment of advanced bladder cancer.
@en
prefLabel
The treatment of advanced bladder cancer.
@en
P1433
P1476
The treatment of advanced bladder cancer.
@en
P2093
C N Sternberg
P304
P356
10.1093/OXFORDJOURNALS.ANNONC.A059105
P577
1995-02-01T00:00:00Z